MAGGI, CLAUDIA

MAGGI, CLAUDIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 24 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation 2014 F. PietrantonioF. PerroneF. De BraudC. MaggiGEVORGYAN, ARPINEP. BiondaniF. Festinese + Article (author) -
Bevacizumab treatment in the elderly patient with metastatic colorectal cancer 2015 C. MaggiF. RicchiniF. PietrantonioF. de Braud + Article (author) -
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer : an Italian Trials of Medical Oncology phase II study 2015 F. PietrantonioK. F. DottiC. Maggi + Article (author) -
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies 2014 F. PietrantonioC. MaggiF. RicchiniF. De Braud + Article (author) -
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab 2015 V. MusellaF. PietrantonioC. MaggiF. de Braud + Article (author) -
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer : A systematic review and meta-analysis of published trials 2016 F. PietrantonioC. MaggiF. de Braud + Article (author) -
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer 2016 F. PietrantonioF. de BraudC. MaggiK.F. DottiA. Pellegrinelli + Article (author) -
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan 2015 F.S. FalvellaS. CheliC. MazzaliC. MaggiM. Di BartolomeoI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer : a systematic review and meta-analysis 2015 F. PietrantonioF. PetrelliM. Di BartolomeoC. MaggiF. de Braud + Article (author) -
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma 2014 F. PietrantonioC. MaggiG. FanettiF. RicchiniI. BossiG. PelosiF. de Braud + Article (author) -
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status 2014 F. PietrantonioC. MaggiI. BossiG. PelosiF. De Braud + Article (author) -
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study 2016 F. PietrantonioC. MaggiM. NigerA. MennittoF. de Braud + Article (author) -
In reply 2015 C. MaggiF. DebraudF. Pietrantonio + Article (author) -
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil : a meta-analysis of published trials 2014 F. PietrantonioC. MaggiF. RicchiniF. De Braud + Article (author) -
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases 2015 F. PietrantonioV. MazzaferroCOTSOGLOU, CHRISTIANG. FanettiP. BiondaniC. MaggiF. de Braud + Article (author) -
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab : a meta-analysis 2015 F. PietrantonioK. BorgonovoC. MaggiF. De Braud + Article (author) -
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 2019 Vernieri, ClaudioMennitto, AlessiaMaggi, ClaudiaPrisciandaro, MicheleFabbroni, Chiarade Braud, Filippo + Article (author) -
Role of cMET in the development and progression of colorectal cancer 2013 P. BiondaniC. MaggiF. de BraudF. Pietrantonio + Article (author) -
Role of MGMT as biomarker in colorectal cancer 2014 G. FanettiC. MaggiF. de BraudF. Pietrantonio + Article (author) -
Single agent panitumumab in kras wild-type metastatic colorectal cancer patients following cetuximab-based regimens 2013 F. PietrantonioP. BiondaniC. MaggiF. VenturiniG. FanettiF. De Braud + Article (author) -